某三甲医院恶性肿瘤患者抗肿瘤药物静脉输液顺序的调查分析<sup>★</sup>

doi:10.3969/j.issn.2095-1264.2022.01.17

首页 > 过刊浏览>2022年第1期 >112-116. DOI:10.3969/j.issn.2095-1264.2022.01.17

某三甲医院恶性肿瘤患者抗肿瘤药物静脉输液顺序的调查分析★
DOI:
                        10.3969/j.issn.2095-1264.2022.01.17
                    
作者:
                        
                        
                    
作者单位:1.南京医科大学附属南京医院/南京市第一医院，药学部，江苏 南京，210006;2.南京医科大学附属南京医院/南京市第一医院，肿瘤内科，江苏 南京，210006
作者简介:李杨，男，硕士，主管药师，研究方向：临床药学及合理用药。
通讯作者:吴贤翠，女，学士，副主任护师，研究方向：临床护理及护理管理。
中图分类号:R979.1;R969
基金项目:

Investigation and analysis on the sequence of intravenous infusion of anti-tumor drugs for patients with malignant tumors in a hospital^★

Author:

Affiliation:

1.Department of Pharmacy, Nanjing Hospital Affiliated to Nanjing Medical University/Nanjing First Hospital, Nanjing, Jiangsu, 210006, China;2.Department of Oncology, Nanjing Hospital Affiliated to Nanjing Medical University/Nanjing First Hospital, Nanjing, Jiangsu, 210006, China

Fund Project:

摘要

图/表

访问统计

参考文献

相似文献

引证文献

资源附件

文章评论

摘要:

目的分析我院肿瘤内科2019年第4季度恶性肿瘤住院患者药物联合治疗输液顺序的合理性，为临床合理用药提供参考。方法制定抗肿瘤药物联合治疗静脉输液顺序合理性评价标准，提取我院肿瘤内科2019年第4季度接受药物联合治疗患者输液卡上治疗药物的输液时间，分析并评价药物联合治疗输液顺序的合理性。结果 2019年第4季度我院肿瘤内科接受药物联合治疗的患者共计215例次，涉及治疗方案37种。其中3种治疗方案输液顺序不合理，涉及患者10例次，占比12.7%。结论我院肿瘤内科2019年第4季度抗肿瘤药物联合治疗静脉输液顺序总体合理，但仍存在一些亟需改进的不合理之处，以进一步提高合理用药水平。

Abstract:

Objective To analyze the rationality of the intravenous infusion sequence of drugs for inpatients with malignant tumors during the fourth quarter of 2019 in our oncology department, and to provide a reference for clinical rational drug use.Methods The evaluation criteria for rationality of intravenous infusion sequence of anti-tumor drugs in combination therapy were formulated, and the drug infusion time on the card of patients who received drug-combination therapy in the fourth quarter of 2019 was extracted. Then the rationality of drug infusion sequence was evaluated and analyzed.Results In the fourth quarter of 2019, a total of 215 person-time received combination therapy with anti-tumor drugs in the oncology department, involving 37 treatment protocols. There were 3 treatment protocols with improper drug infusion sequence, involving 10 person-time, accounting for 12.7%.Conclusion In the fourth quarter of 2019, the intravenous infusion sequence of anti-tumor drugs in the combination therapy was generally reasonable in the oncology department of our hospital, but there were still a few unreasonable points that need to be improved to further increase the level of rational drug use.